A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Pivotal Reaserch Centers, Peoria

Boehringer Ingelheim Investigational Site, Tucson

PMDI, Fountain Valley

Boehringer Ingelheim Investigational Site, Fresno

Boehringer Ingelheim Investigational Site, Irvine

Boehringer Ingelheim Investigational Site, Ocenside

Boehringer Ingelheim Investigational Site, Oxnard

West Los Angeles VA Medical Center, West Los Angeles

Boehringer Ingelheim Investigational Site, Danbury

UCONN Health Center, Farmington

60 Temple St, New Haven

Boehringer Ingelheim Investigational Site, Boca Raton

Boehringer Ingelheim Investigational Site, Bradenton

University of Florida, Gainsville

Sunrise Clinical Research, Hollywood

Department of Neurology, Miami

Miami Research Associates, Miami

Boehringer Ingelheim Investigational Site, Ocala

Renstar Medical Research, Ocala

Boehringer Ingelheim Investigational Site, Panama City

CNS Clinical Trials, Saint Piresburg

Movement Disorder Center, Tampa

University of Southern Florida, Tampa

Department of Neurological Sciences, Chicago

Boehringer Ingelheim Investigational Site, Fort Wayne

Outpatient Clinical Research Facility, Indianapolis

Boehringer Ingelheim Investigational Site, Kansas City

Boehringer Ingelheim Investigational Site, Shreveport

Boehringer Ingelheim Investigational Site, Scarborough

Boehringer Ingelheim Investigational Site, Springfield

Future Care Studies, Springfield

Boehringer Ingelheim Investigational Site, Traverse City

Boehringer Ingelheim Investigational Site, Minneapolis

University of Minesota, Minneapolis

Boehringer Ingelheim Investigational Site, Omaha

University of Nebraska Medical Center, Omaha

Global Medical Institutes LLC, Toms River

Upstate Clinical Resaerch LLC, Albany

Boehringer Ingelheim Investigational Site, New York

Boehringer Ingelheim Investigational Site, Wiston-Salem

Ohio State University Medical Center, Columbus

Neurology Specialists Inc., Dayton

St. John's Doctor Building, Tulsa

University of Pittsburgh Medical Center, Pittsburgh

The Methodist Hospital, Houston

Boehringer Ingelheim Investigational Site, San Antonio

North Texas Neurology Associates, Wichita Falls

University of Calgary, Calgary

University of British Columbia, Vancouver

Davidson Memory Clinic, Moncton

Boehringer Ingelheim Investigational Site, Halifax

Centre For Movement Disorders, Markham

Clinical Research Consultant Group, Beaconsfield

Memory and Motor Skills Disorders Clinic, Québec

Boehringer Ingelheim Investigational Site, Saskatoon